"
SWAP COUNTERPARTY & REFERENCE OBLIGATION","
BUY/SELLPROTECTION","
NOTIONALAMOUNT(000)","
INTERESTRATE","
TERMINATIONDATE","
UNREALIZEDAPPRECIATION(DEPRECIATION)","
UPFRONTPAYMENTSPAID(RECEIVED)","
VALUE","
CREDITRATING OFREFERENCEOBLIGATION ",CIK,Reporting Type,Report Year
"
Barclays Bank PLCYum! Brands, Inc.","
Buy","
825000",1.0,"
12/20/18","
(2,064","
(14,319","
(16,383","
BBB",0000716716,N-CSR,15
"
Barclays Bank PLCDiagnostics, Inc.","
Buy","
845000",1.0,"
03/20/19","
(27,733","
16,218","
(11,515","
BBB+",0000716716,N-CSR,15
"
Morgan Stanley & Co., LLC* CDX.NA.HY.21","
Buy","
1,287000",5.0,"
12/20/18","
12,830","
(106,944","
(94,114","
NR",0000716716,N-CSR,15
"
Morgan Stanley & Co., LLC* CDX.NA.IG.22","
Buy","
718000",5.0,"
6/20/19","
4,850","
(54,744","
(49,894","
NR",0000716716,N-CSR,15
"
Morgan Stanley & Co., LLC* CDX.NA.IG.22","
Buy","
11,650000",1.0,"
12/20/19","
(2,877","
(186,368","
(189,245","
NR",0000716716,N-CSR,15
